Novartis AG (SWX:NOVN) submitted a written non-binding indication of interest to acquire Regulus The

Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition o

Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation

Entered into an agreement to be acquired by Novartis for $7.00 per share in cash, with potential to

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

NEW YORK , April 30, 2025 /PRNewswire/ -- Monteverde & Associates PC  (the "M&A Class Action Firm"),

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Wednes

Novartis AG NVS agreed to acquire Regulus Therapeutics Inc.  RGLS on Wednesday for an initial paymen

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Regulus (Nasdaq: RGLS) for possible brea

Swiss drugmaker Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion to gain acces

Basel, April 30, 2025 – Novartis today announced that it has entered into an agreement to acquire Re

Novartis to acquire Regulus for $7.00 per share in cash, with potential to receive an additional $7.

Regulus Therapeutics Inc. (RGLS) reached a significant support level, and could be a good pick for i

SAN DIEGO , April 2, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceuti

Regulus Therapeutics Inc. RGLS released topline results from all patients in the fourth cohort in it

Positive Topline Data from the Fourth Cohort of Patients Consistent demonstration of polycystin (PC)

If you're one of the over 4 Million Americans set to retire this year, you may want to pay attention

Regulus (RGLS) might move higher on growing optimism about its earnings prospects, which is reflecte

Positive topline results from an interim analysis of the fourth cohort of patients in the Phase 1b m

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the com

U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on T

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Tue

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Tuesd

  On Monday, 198 companies hit new 52-week lows.

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has rece

  Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarte

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarter

  Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday a

  During Wednesday's trading, 435 companies set new 52-week lows.

  Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly l

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on t

Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumpi

    On Thursday, 615 stocks hit new 52-week lows.

    On Monday morning, 60 companies achieved new lows for the year.

  Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly lo

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wedn